Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

erythrocyte Membrane Protein Band 4.2 (EPB42) Peptid

EPB42 Wirt: Synthetic BP, WB
Produktnummer ABIN8099818
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für erythrocyte Membrane Protein Band 4.2 (EPB42) Peptid (ABIN8099818)

Target

EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Verwendungszweck

    EPB42 Peptide
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-EPB42 antibody ( ARP33799_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))

    Hintergrund

    Background Information: Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia.

    Alternative Symbols: PA, SPH5

    Molekulargewicht

    80kDa

    Gen-ID

    2038

    NCBI Accession

    NP_000110

    UniProt

    P16452
Sie sind hier:
Chat with us!